Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Correspondence:
Submit a response
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrowRequest Permissions
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial
Neurology Sorenson et al. 71: 1770

Korean Translation

Files in this Data Supplement:



This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Correspondence:
Submit a response
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrowRequest Permissions